It is an International Equity Fund that will maintain a minimum of 65% of its exposure to the Health Care and Innovation sectors:
Within the health care sector, the fund may choose traditional stocks, such as those related to pharmaceuticals and medical device companies, as well as companies that are more closely related to research and development, such as companies with a profile linked to biotechnology.
The focus on innovation is a key pillar of the fund’s value strategy. Innovative companies lead long-term growth. Investing in them is betting on the future, selecting companies that not only serve today’s needs, but are also prepared to adapt and lead the future.
The Fund has an Class A of units aimed at the general public and a Class C with a minimum initial investment, as well as a minimum investment to be held, of €500,000 for retail investors and €1 for institutional investors.
David Horna Marcos
Alfredo Coppola
